Found: 7
Select item for more details and to access through your institution.
Health economics perspective of fesoterodine, tolterodine or solifenacin as first-time therapy for overactive bladder syndrome in the primary care setting in Spain.
- Published in:
- BMC Urology, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2490-13-51
- By:
- Publication type:
- Article
Health economics perspective of fesoterodine, tolterodine or solifenacin as first-time therapy for overactive bladder syndrome in the primary care setting in Spain.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Antimuscarinic persistence patterns in newly treated patients with overactive bladder: a retrospective comparative analysis.
- Published in:
- International Urogynecology Journal, 2014, v. 25, n. 4, p. 485, doi. 10.1007/s00192-013-2250-4
- By:
- Publication type:
- Article
European content validation of the Self-Assessment Goal Achievement (SAGA) questionnaire in patients with overactive bladder.
- Published in:
- International Urogynecology Journal, 2013, v. 24, n. 9, p. 1529, doi. 10.1007/s00192-012-2039-x
- By:
- Publication type:
- Article
Cost Effectiveness of Fesoterodine and Tolterodine for the Treatment of Overactive Bladder with Urge Urinary Incontinence in Spain and Finland.
- Published in:
- Clinical Drug Investigation, 2014, v. 34, n. 5, p. 297, doi. 10.1007/s40261-014-0178-1
- By:
- Publication type:
- Article
Meta-analysis of outcome studies in end-stage renal disease.
- Published in:
- Kidney International, 2000, v. 57, p. S28, doi. 10.1046/j.1523-1755.2000.07406.x
- By:
- Publication type:
- Article
Meta-analysis of outcome studies in end-stage renal disease.
- Published in:
- Kidney International Supplement, 2000, n. 74, p. S-28
- By:
- Publication type:
- Article